206 related articles for article (PubMed ID: 18506635)
1. Neurotrophic actions of PACAP-38 and LIF on human neuroblastoma SH-SY5Y cells.
Monaghan TK; Pou C; MacKenzie CJ; Plevin R; Lutz EM
J Mol Neurosci; 2008 Nov; 36(1-3):45-56. PubMed ID: 18506635
[TBL] [Abstract][Full Text] [Related]
2. PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases.
Monaghan TK; Mackenzie CJ; Plevin R; Lutz EM
J Neurochem; 2008 Jan; 104(1):74-88. PubMed ID: 17995938
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. A novel VIP-independent action of PHI via MAP kinase.
Lelièvre V; Pineau N; Du J; Wen CH; Nguyen T; Janet T; Muller JM; Waschek JA
J Biol Chem; 1998 Jul; 273(31):19685-90. PubMed ID: 9677397
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory effect of pituitary adenylate-cyclase activating polypeptide (PACAP) and its PACAP type I receptor (PAC1R) on prolactin synthesis in rat pituitary somatolactotroph GH3 cells.
Mijiddorj T; Kanasaki H; Purwana IN; Oride A; Miyazaki K
Mol Cell Endocrinol; 2011 Jun; 339(1-2):172-9. PubMed ID: 21539889
[TBL] [Abstract][Full Text] [Related]
5. Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells.
Cavallaro S; D'Agata V; Guardabasso V; Travali S; Stivala F; Canonico PL
Mol Pharmacol; 1995 Jul; 48(1):56-62. PubMed ID: 7623775
[TBL] [Abstract][Full Text] [Related]
6. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates proliferation of reactive astrocytes in vitro.
Nakamachi T; Nakamura K; Oshida K; Kagami N; Mori H; Watanabe J; Arata S; Yofu S; Endo K; Wada Y; Hori M; Tsuchikawa D; Kato M; Shioda S
J Mol Neurosci; 2011 Jan; 43(1):16-21. PubMed ID: 20574684
[TBL] [Abstract][Full Text] [Related]
8. Vanadate stimulates differentiation and neurite outgrowth in rat pheochromocytoma PC12 cells and neurite extension in human neuroblastoma SH-SY5Y cells.
Rogers MV; Buensuceso C; Montague F; Mahadevan L
Neuroscience; 1994 May; 60(2):479-94. PubMed ID: 7521024
[TBL] [Abstract][Full Text] [Related]
9. Role of transglutaminase 2 in PAC
Algarni AS; Hargreaves AJ; Dickenson JM
Biochem Pharmacol; 2017 Mar; 128():55-73. PubMed ID: 28065858
[TBL] [Abstract][Full Text] [Related]
10. PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.
Brown D; Tamas A; Reglödi D; Tizabi Y
J Mol Neurosci; 2013 Jul; 50(3):600-7. PubMed ID: 23625270
[TBL] [Abstract][Full Text] [Related]
11. Src family kinase inhibitors blunt PACAP-induced PAC1 receptor endocytosis, phosphorylation of ERK, and the increase in cardiac neuron excitability.
Tompkins JD; Clason TA; Buttolph TR; Girard BM; Linden AK; Hardwick JC; Merriam LA; May V; Parsons RL
Am J Physiol Cell Physiol; 2018 Feb; 314(2):C233-C241. PubMed ID: 29141923
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
Borba JC; Henze IP; Silveira MS; Kubrusly RC; Gardino PF; de Mello MC; Hokoç JN; de Mello FG
Brain Res Dev Brain Res; 2005 May; 156(2):193-201. PubMed ID: 16099306
[TBL] [Abstract][Full Text] [Related]
13. Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons.
Takei N; Skoglösa Y; Lindholm D
J Neurosci Res; 1998 Dec; 54(5):698-706. PubMed ID: 9843161
[TBL] [Abstract][Full Text] [Related]
14. Maxadilan interacts with receptors for pituitary adenylyl cyclase activating peptide in human SH-SY5Y and SK-N-MC neuroblastoma cells.
Eggenberger M; Born W; Zimmermann U; Lerner EA; Fischer JA; Muff R
Neuropeptides; 1999 Apr; 33(2):107-14. PubMed ID: 10657479
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) are positioned to modulate afferent signaling in the cochlea.
Drescher MJ; Drescher DG; Khan KM; Hatfield JS; Ramakrishnan NA; Abu-Hamdan MD; Lemonnier LA
Neuroscience; 2006 Sep; 142(1):139-64. PubMed ID: 16876955
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenylate cyclase-activating polypeptide (PACAP) as a growth hormone (GH)-releasing factor in grass carp. I. Functional coupling of cyclic adenosine 3',5'-monophosphate and Ca2+/calmodulin-dependent signaling pathways in PACAP-induced GH secretion and GH gene expression in grass carp pituitary cells.
Wong AO; Li W; Leung CY; Huo L; Zhou H
Endocrinology; 2005 Dec; 146(12):5407-24. PubMed ID: 16123157
[TBL] [Abstract][Full Text] [Related]
17. PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity.
Manavalan S; Getachew B; Manaye KF; Khundmiri SJ; Csoka AB; McKinley R; Tamas A; Reglodi D; Tizabi Y
Neurotox Res; 2017 Jul; 32(1):8-13. PubMed ID: 28342135
[TBL] [Abstract][Full Text] [Related]
18. VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells.
de Boisvilliers M; Perrin F; Hebache S; Balandre AC; Bensalma S; Garnier A; Vaudry D; Fournier A; Festy F; Muller JM; Chadéneau C
Peptides; 2016 Apr; 78():30-41. PubMed ID: 26826611
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid regulation of the VIP and PACAP autocrine ligand and receptor system in human neuroblastoma cell lines.
Waschek JA; Lelievre V; Bravo DT; Nguyen T; Muller JM
Peptides; 1997; 18(6):835-41. PubMed ID: 9285932
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase-activating polypeptide (PACAP) alters parasympathetic neuron gene expression in a time-dependent fashion.
Sumner AD; Margiotta JF
J Mol Neurosci; 2008 Nov; 36(1-3):141-56. PubMed ID: 18594777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
